A clinicopathologic study of patients with hemorrhagic myocardial infarction treated with selective coronary thrombolysis with urokinase.
Revision as of 03:28, 20 August 2022 by 187.21.138.9 (talk) (Created page with "== Target Article == A clinicopathologic study of patients with hemorrhagic myocardial infarction treated with selective coronary thrombolysis with urokinase.; H Fujiwara, T Onodera, M Tanaka, T Fujiwara, DJ Wuae; 1986; doi_citing_unknown == Retraction == The no reflow phenomenon: a time-limiting factor for reperfusion after coronary occlusionchar(39) ; John R Darsee Robert A Kloner; 11/01/1980 ; https://doi.org/10.1016/0002-9149(80)90431-2 == Citation piece == Note:...")
Target Article[edit | edit source]
A clinicopathologic study of patients with hemorrhagic myocardial infarction treated with selective coronary thrombolysis with urokinase.; H Fujiwara, T Onodera, M Tanaka, T Fujiwara, DJ Wuae; 1986; doi_citing_unknown
Retraction[edit | edit source]
The no reflow phenomenon: a time-limiting factor for reperfusion after coronary occlusionchar(39) ; John R Darsee Robert A Kloner; 11/01/1980
Citation piece[edit | edit source]
Note: Open to append information.